1. Home
  2. HXHX vs LYRA Comparison

HXHX vs LYRA Comparison

Compare HXHX & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HXHX
  • LYRA
  • Stock Information
  • Founded
  • HXHX 2003
  • LYRA 2005
  • Country
  • HXHX China
  • LYRA United States
  • Employees
  • HXHX N/A
  • LYRA N/A
  • Industry
  • HXHX Trucking Freight/Courier Services
  • LYRA Medical/Dental Instruments
  • Sector
  • HXHX Industrials
  • LYRA Health Care
  • Exchange
  • HXHX Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • HXHX 13.3M
  • LYRA 11.3M
  • IPO Year
  • HXHX 2025
  • LYRA 2020
  • Fundamental
  • Price
  • HXHX $1.19
  • LYRA $6.27
  • Analyst Decision
  • HXHX
  • LYRA Hold
  • Analyst Count
  • HXHX 0
  • LYRA 1
  • Target Price
  • HXHX N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • HXHX 234.7K
  • LYRA 15.1K
  • Earning Date
  • HXHX 01-01-0001
  • LYRA 11-11-2025
  • Dividend Yield
  • HXHX N/A
  • LYRA N/A
  • EPS Growth
  • HXHX N/A
  • LYRA N/A
  • EPS
  • HXHX 0.26
  • LYRA N/A
  • Revenue
  • HXHX $25,571,810.00
  • LYRA $770,000.00
  • Revenue This Year
  • HXHX N/A
  • LYRA N/A
  • Revenue Next Year
  • HXHX N/A
  • LYRA $123.46
  • P/E Ratio
  • HXHX $5.14
  • LYRA N/A
  • Revenue Growth
  • HXHX N/A
  • LYRA N/A
  • 52 Week Low
  • HXHX $0.84
  • LYRA $3.81
  • 52 Week High
  • HXHX $6.29
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • HXHX N/A
  • LYRA 35.00
  • Support Level
  • HXHX N/A
  • LYRA $6.15
  • Resistance Level
  • HXHX N/A
  • LYRA $6.72
  • Average True Range (ATR)
  • HXHX 0.00
  • LYRA 0.38
  • MACD
  • HXHX 0.00
  • LYRA -0.04
  • Stochastic Oscillator
  • HXHX 0.00
  • LYRA 15.99

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: